- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.18 Form of Restricted Share Unit Agreement Under the 2019 Equity Compensation Plan
- 10.19 Form of Restricted Share Unit Agreement (Israeli Directors and Officers) Under the 2019 Equity Compensation Plan
- 10.20 Form of Restricted Stock Unit Agreement (Employees) Under the 2019 Equity Compensation Plan
- 10.28 Letter Agreement by and Between Pluristem LTD. and Rose High Tech LTD., Dated September 13, 2021
- 10.29 Letter Agreement by and Between Pluristem LTD. and Yaky Yanay, Dated September 13, 2021
- 10.30 Letter Agreement by and Between Pluristem LTD. and Chen Franco-yehuda, Dated September 13, 2021
- 23.1 Consent of Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global
- 23.2 Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-239890) and in the Registration Statement on Form S-8 (Registration No. 333- 248685, 333-248686, , 333-229535, 333-222888, 333-217770, 333-212299, 333-206848, 333-196537, 333-173777 and 333-162577) pertaining to the Amended and Restated 2005 Stock Option Plan, the 2016 Equity Compensation Plan and the 2019 Equity Compensation Plan of Pluristem Therapeutics Inc. of our report dated September 10, 2020, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., included in this Annual Report (Form 10-K) of Pluristem Therapeutics Inc., dated September 13, 2021.
Tel Aviv, Israel | /s/ Kost Forer Gabbay & Kasierer | |
September 13, 2021 | A Member of Ernst & Young Global |
A member firm of Ernst & Young Global Limited